Table 2.
Comparison of superoxide dismutase and malondialdehyde concentrations of control and patients with rheumatoid arthritis
| Control | Diclofenac |
Meloxicam |
Celecoxib |
||||
|---|---|---|---|---|---|---|---|
| Baseline | Final | Baseline | Final | Baseline | Final | ||
| SOD (U/mgHb) | 7.02±0.58 | 3.31±0.83* | 5.57±0.68 | 3.58±0.74* | 5.05±0.72#,ª | 3.41±1.2$ | 5.3±0.69 |
| Mean change | 0.682 | 0.411 | 0.554 | ||||
| MDA (μmol/L) | 3.01±0.25 | 5.87±1.0$ | 2.94±0.42# | 5.71±0.55* | 3.03±0.32# | 6.84±0.84* | 2.75±0.25# |
| Mean change | −0.499 | −0.469 | −0.597 | ||||
All values expressed in mean±SE. *P<0.01; $P<0.05, in corresponding group compared to control; #P<0.05 as compared to baseline in treatments groups; ªP<0.05 as compared to controls. SOD: Superoxide dismutase; MDA: Malondialdehyde